CXCL9 and intrahepatic cholangiocarcinoma: Endogenous CXCL9 affects tumor progression and postoperative survival in intrahepatic cholangiocarcinoma patients by regulating tumor-infiltrating NK cells, which was also validated in mouse models 120.